Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Medical
SmallCapReview.com Initiates Coverage of Lipocine (Nasdaq: LPCN)
Jun 20 2017 @ 08:19
SmallCapReview.com, A leading site for news and information on Small-Caps and MicroCaps is adding Liposcine (LPCN...
SmallCapReview Initiates Coverage of Myriad Genetics (MYGN)
Feb 08 2017 @ 09:17
SmallCapReview.com, A leading site for news and information on small caps, penny stocks and microcaps is adding...
AcelRx Stock Price Likely To Continue Climbling With FDA Approval Near
Jul 02 2014 @ 04:51
Summary AcelRx develops Zalviso to treat acute and breakthrough pain. We believe there is a 90% chance the company...
Volcano Corp Is Likely To Be Acquired
Jun 12 2014 @ 10:17
Summary In the area of acquisitions, we’ve had a solid history of very accurate behavior-based predictions...
Progenics Pharma's June 11th Adcom Likely To Attract Biotech Catalyst Traders
May 29 2014 @ 19:45
Progenics is expecting a Food and Drug Administration (FDA) Advisory Committee meeting on June 11 – 12 to...
Orexigen Poised to Move Higher On Drug Approval And Techincal Chart
May 27 2014 @ 18:14
Coming up on June 10th, 2014, Orexigen Therapeutics expects a Food and Drug Administration (FDA) for it’s weight...
Did Pozen Mislead Investors Concerning Its Recent FDA Rejection?
Apr 28 2014 @ 09:42
On Friday of last week, Pozen Inc.(POZN), received a CRL from the FDA, disallowing the New Drug Application (NDA...
High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued
Apr 01 2014 @ 09:18
Although we generally look for long plays in the biotechnology sector, certain macroeconomic factors can force us...
Biotech Catalyst Trade In Focus: Synthetic Biologics Upcoming Multiple Sclerosis Data Catalyst
Mar 10 2014 @ 02:27
Similar to how a blue-chip company might have an increase in stock price before an earnings call, small-cap...
Xenoport Gaining Momentum, Could It Be The Next Small Cap Biotech Flyer?
Feb 25 2014 @ 08:00
Xenoport (XNPT) focuses on developing and commercializing a portfolio of internally discovered product candidates...
